Načítá se...
Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme
Ubiquitin-like (Ubl) posttranslational modifications are potential targets of therapeutics. However, the only known mechanism for inhibiting a Ubl activating enzyme is through targeting its ATP-binding site. Here we identify an allosteric inhibitory site in the small ubiquitin-like modifier (SUMO) a...
Uloženo v:
| Vydáno v: | Cell Chem Biol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524651/ https://ncbi.nlm.nih.gov/pubmed/30581133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2018.10.026 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|